DSpace About DSpace Software
 

IRZSMU >
Кафедри >
Кафедра фармакогнозії, фармакології та ботаніки >
Наукові праці. (Фармакогнозія) >

Please use this identifier to cite or link to this item: http://dspace.zsmu.edu.ua/handle/123456789/5279

Название: Antioxidant Therapy as a Protector and Corrector of Haematological Toxicity of Systemic Therapy for Breast Cancer
Авторы: Prokhach, A. V.
Bondarenko, I. M.
Kulinich, R. V.
Bukhtiyarova, N. V.
Кулинич, Роман Леонідович
Бухтіярова, Ніна Вікторівна
Ключевые слова: Breast cancer
hematological toxicity
leucopenia
chemotherapy
antioxidant therapy
Issue Date: 2016
Библиографическое описание: Antioxidant Therapy as a Protector and Corrector of Haematological Toxicity of Systemic Therapy for Breast Cancer / A. V. Prokhach, I. M. Bondarenko, R. V. Kulinich, N. V. Bukhtiyarova // Biological Markers and Guided Therapy. - 2016, Vol. 3, № 1. – Р. 193-198.
Аннотация: Side effects of anticancer drugs seriously limit the achievement of the maximum therapeutic effect of the most cytostatics. Pathophysiological basis of side effects is the ability of cytotoxic agents to intensify the free-radical processes and the con sequent lipid peroxidation (LPO) in the cell membranes of various organs. In our study we observed the efficacy of antioxidant therapy in the prevention of the development of leukopenia. It was discovered that administration of antioxidant therapy during course of chemotherapy for breast cancer leads to significantly lower incidence of leukopenia (78.5% of cases in control group versus 43.8% in study group with study drug), and lower incidence of deep leukopenia. Also in was found that patients with a low level of SH-groups (less than 1 mmol / g protein) in parallel activation of oxidative stress are in the risk group for the occurrence of neutropenia in the background of breast cancer chemotherapy and require dynamic observation with individual selection of donators thiols and drugs with proven antioxidant effect. Reduction in the activity of antioxidant enzymes of glutathione level and the displacement of the thiol-disulfide equilibrium in the direction of reducing of the content of reduced forms indicates a reliable clinical need for the personal use of drugs with glutathione-protective effect and antioxidant potential.
URI: http://dspace.zsmu.edu.ua/handle/123456789/5279
Appears in Collections:Наукові праці. (Фармакологія та МР)
Наукові праці. (Фармакогнозія)

Files in This Item:

File Description SizeFormat
1601_193-198.pdf149,62 kBAdobe PDFView/Open
View Statistics

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2010  Duraspace - Feedback